Sibutramine Production Cost Reports

The report provides a detailed analysis essential for establishing a sibutramine production plant. It encompasses all critical aspects necessary for sibutramine production, including the cost of sibutramine production, sibutramine plant cost, sibutramine production costs, and the overall sibutramine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a sibutramine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Sibutramine is a serotonin-norepinephrine reuptake inhibitor that is approved for long-term obesity management as an adjunct to diet and exercise. It promotes weight loss through appetite suppression, increased satiety, and modest thermogenesis. It is used for the treatment of moderate to severe obesity in adults with a BMI above thirty or above twenty-seven with comorbidities like hypertension, type diabetes, or dyslipidemia.

It shows sustained reductions in body weight along with improvements in waist circumference, lipid profiles, glycemic control, and quality of life. It was also explored for binge eating disorder, polycystic ovary syndrome-associated obesity, and hypothalamic obesity. Its common side effects include dry mouth, constipation, insomnia, headache, nausea, dizziness, tachycardia, palpitations, hypertension, anxiety, etc.

The market for sibutramine is fuelled by the global obesity epidemic and rising demand for effective pharmacotherapy in weight management, along with diet and exercise. The expanding healthcare access in emerging markets, where it remains available for treating moderate to severe obesity, contributes to its market growth.

The reliance on generic production from Asian manufacturers and regulatory approvals in select regions, driving hospital and retail pharmacy distribution, affects industrial sibutramine procurement. The cost advantages over branded alternatives and supply chain logistics favouring bulk imports to high-prevalence areas impact its sourcing strategies. Also, challenges from varying safety standards, competition from newer agents, and pharmacovigilance requirements affect its market dynamics.

Raw Material for Sibutramine Production

According to the sibutramine production plant project report, the key raw materials used in the production of sibutramine include 4-chlorophenyl acetonitrile, methyl isobutyl ketone, paraformaldehyde, and formic acid.

Production Process of Sibutramine

The extensive sibutramine production cost report consists of the following major industrial production process:

1. From 4-chlorophenyl acetonitrile and methyl isobutyl ketone: The production process of sibutramine involves a multi-step process. It starts with the condensation of 4-chlorophenyl acetonitrile and methyl isobutyl ketone to form 1-[1-(4-chlorophenyl)cyanobutyl]-3-methylbutan-1-one. This is followed by cyclisation to get N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}formamide. Its hydrolysis with NaOH, extraction, and acidification produce the amine hydrochloride intermediate. After that, this condenses amine with formic acid and paraformaldehyde to get sibutramine base, which is then converted to the hydrochloride salt.

Sibutramine has the molecular formula of C17H26ClN and a molecular weight of 279.85 g/mol. Its hydrochloride salt has the molecular formula of C17H26ClN·HCl and appears as a white to off-white solid. It has a melting point of 191–192 degrees Celsius with a boiling point around 343 degrees Celsius. It has a density of around 1.03 g/cm³ and low water solubility, but slight solubility in solvents like chloroform, DMSO, and ethyl acetate. It has a cyclobutylbenzene core with a para-chloro substituent, a tertiary amine (N, N-dimethyl), and an isobutyl amine side chain. It has a pKa value of 9.7 and a lipophilic character ideal for CNS penetration as a serotonin and norepinephrine reuptake inhibitor.